The management of spasticity.
Spasticity is a frequent feature of neurological disease in adults and children. Commonly associated symptoms include impaired movement, painful muscle spasms, stiffness and disturbed sleep. Severe or long-standing spasticity may lead to contractures and joint ankylosis, which can severely restrict the patient's care and rehabilitation. Here, we review the management of patients with spasticity, concentrating on the role of drug treatment.
D000284:Administration, Oral; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D001569:Benzodiazepines; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D006801:Humans; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D009128:Muscle Spasticity / Q000188:drug therapy*; D009465:Neuromuscular Agents / Q000627:therapeutic use
D014151:Anti-Anxiety Agents; D009125:Muscle Relaxants, Central; D009465:Neuromuscular Agents; D001569:Benzodiazepines; D019274:Botulinum Toxins, Type A